Glenmark Pharmaceuticals Limited (BOM:532296)
India · Delayed Price · Currency is INR 2,300.35
+31.45 (1.39%)
At close: Oct 28, 2026
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 649.06 billion as of October 28, 2026. Its market cap has increased by 26.88% in one year.
Market Cap
649.06B
Enterprise Value
643.23B
Revenue
177.37B
Global Rank
n/a
Country Rank
n/a
PE Ratio
36.12
ChartMarket Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 649.06B, an increase of 56,374.38%. That is a compound annual growth rate of 28.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 649.06B | 13.01% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 1.18T |
| Zydus Lifesciences | 1.17T |
| Cipla | 1.10T |
| Mankind Pharma | 1.03T |
| Aurobindo Pharma | 946.38B |
| Glenmark Pharmaceuticals | 649.06B |
| Alkem Laboratories | 606.19B |
| Gland Pharma | 501.99B |